The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

While the FDA, European Medicines Agency (EMA), and the UK’s Medicines ... as specified in the recent EU pharmacovigilance legislation. Examining the findings of the MHRA’s most recent ...

The European Medicines Agency (EMA) says its safety committee has begun a review into reports of an association between use of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and a ...

Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency ... in approvals and pharmacovigilance for two ...

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by ...

In late January, the European Medicines Agency (EMEA) finally reached a ... manufacturers will also be required to carry out extended pharmacovigilance. At least the EMEA has done some ...

The European Medicines Agency (EMA) modified the leaflets of ... El Economista reported that the Navarra Pharmacovigilance Center raised alarms about this unexpected side effect after detecting ...

The results of a nine-month investigation by health regulators in the European Union should be comforting for anyone taking Ozempic and other similar drugs to treat type 2 diabetes and/or obesity.